Location History:
- Hettstadt, DE (2016 - 2018)
- Heiligenhaus-Isenbuegel, DE (2024)
Company Filing History:
3 out of 74 
1 out of 122 
1 out of 17 Years Active: 2016-2024
Title: The Innovative Contributions of Christoph Kleinschnitz
Introduction: Christoph Kleinschnitz is a prominent inventor based in Hettstadt, Germany. With a focus on neurological therapies, he has made significant contributions to the medical field through his patented inventions. His work emphasizes innovative approaches to treating neurotraumatic disorders and inflammatory diseases of the nervous system.
Latest Patents: Christoph Kleinschnitz holds three patents, showcasing his expertise in the treatment of neurological conditions. His latest patents include:
1. **Therapy Using a Factor XII Inhibitor in a Neurotraumatic Disorder:** This invention focuses on utilizing a direct Factor XII (FXII) inhibitor to treat traumatic brain injuries and spinal cord injuries, aiming to mitigate the damage caused by such injuries.
2. **Factor XII Inhibitors for the Treatment of Neurological Inflammatory Disorders:** This application pertains to neurological inflammatory diseases, such as multiple sclerosis. It explores methods of administering a Factor XII inhibitor to prevent, treat, or alleviate the impacts of these diseases, alongside providing agents and pharmaceutical compositions that inhibit FXII activity.
Career Highlights: Throughout his career, Christoph Kleinschnitz has worked with notable companies, enhancing his knowledge and expertise. His experience at CSL Behring GmbH and CSL Limited has enriched his understanding of medical innovations, particularly in developing treatments for complex neurological conditions.
Collaborations: Collaboration is key in the field of innovation, and Christoph has worked alongside distinguished colleagues, including Marc Nolte and Sven Meuth. These partnerships have fostered an environment of creativity and advancement in the development of novel therapies.
Conclusion: Christoph Kleinschnitz remains a vital figure in the realm of neurological research and innovation. His patents reflect a deep understanding of the complexities surrounding neurotraumatic disorders and emphasize his commitment to finding effective treatments. As innovations continue to evolve in the medical field, the contributions of inventors like Christoph will be pivotal in shaping future therapies.